Physician

Emmanuel U Sarmiento, MD

According to 2025 Medicare claims, Emmanuel Sarmiento, MD (NPI: 1396747390) practices allergy/immunology in the Greenville-Anderson-Greer, SC market, with the plurality of this provider's patient population coming from Greenville, SC. This provider's primary affiliated billing organization is ALLERGIC DISEASE AND ASTHMA CENTER PA (NPI: 1952302853; TIN: 570673634) and primary practice location at 29607-5910. Sarmiento is affiliated with the CVS ACO (ACO ID: A5407), participating under the MSSP model.

Sarmiento's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 578 traditional Medicare patients, billed 42,789 HCPCS/CPT codes, and received $696,082 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,364 prescription claims across 403 beneficiaries totaling $666,614 in drug costs, led by Dupixent Syringe (Dupilumab). DME data shows 201 claims. Open Payments data shows 217 records totaling $74,291. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $119,471 to $696,082. Similarly, Part D prescription costs have moved sharply higher in recent years, from $134,696 to $666,614. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,626 and ending at $2,802.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	586	12,122	$119,471
2016	708	17,490	$171,519
2017	689	17,470	$192,314
2018	654	15,960	$171,881
2019	608	17,279	$265,238
2020	576	14,826	$212,056
2021	591	15,987	$266,908
2022	603	19,627	$286,759
2023	590	24,790	$392,285
2024	578	42,789	$696,082

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	305	1,492	$134,696
2016	411	2,303	$236,744
2017	412	2,550	$292,068
2018	415	2,437	$351,843
2019	409	2,514	$403,196
2020	385	2,158	$323,342
2021	432	2,371	$387,071
2022	422	2,339	$520,995
2023	407	2,049	$587,370
2024	403	2,364	$666,614

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	175	$100,355
2016	28	250	$135,092
2017	28	280	$118,888
2018	16	288	$124,332
2019	29	322	$176,632
2020	15	323	$189,254
2021	N/R	198	$115,110
2022	13	267	$113,885
2023	13	221	$190,887
2024	N/R	201	$214,569

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	330	582	$87
94010	Test to measure expiratory airflow and volume	155	265	$18
95117	Professional service for multiple injections of allergen	192	1,358	$8
95115	Professional service for single injection of allergen	154	916	$6
89190	Nasal smear for eosinophils (allergy related white blood cells)	181	243	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Syringe	Dupilumab	38	1,204	$161,726
Tezspire	Tezepelumab-Ekko	25	700	$110,845
Xolair	Omalizumab	36	1,008	$87,788
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	101	3,930	$81,484
Breo Ellipta	Fluticasone/Vilanterol	105	4,410	$55,526

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	23	$86,151
J1576	Injection, immune globulin (panzyga), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	26	$77,011
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	12	$35,504
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	39	$12,856
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	13	$940

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	217	$74,291	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Emmanuel U. Sarmiento, MD?

Tedicare shows public-source Medicare data for Emmanuel U. Sarmiento, MD (NPI 1396747390), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emmanuel U. Sarmiento, MD have ACO affiliation data?

Emmanuel U. Sarmiento, MD is shown with ACO affiliation data for CVS ACO (MSSP, ACO ID A5407).

What billing organization is linked to Emmanuel U. Sarmiento, MD?

Emmanuel U. Sarmiento, MD is linked to ALLERGIC DISEASE AND ASTHMA CENTER PA (billing NPI 1952302853) in the available physician profile data.

Does Emmanuel U. Sarmiento, MD have Open Payments data?

Emmanuel U. Sarmiento, MD has 217 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.